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In recent years, the interest in clinical applications of functional neuroimaging
techniques like functional Magnetic Resonance Imaging (fMRI) or modern Magneto- or
Electro- Encephalography (MEG-EEG) has steadily grown as have discussions about
possible standardizations of these methodologies. The modern techniques allow
non-invasive localization of essential brain functions with the potential to extend or
even replace invasive clinical technologies (1–4). The focus of this article is to discuss
standardization options in using functional MRI for clinical cases, mostly in the context
of medical decision aid for planning treatment (radiotherapy and surgery).
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WHAT ARE THE PROBLEMS FOR STANDARDIZING CLINICAL
FUNCTIONAL NEUROIMAGING PROCEDURES?
Functional techniques are complicated and require technical, methodological, and
neurophysiological expert knowledge. For patient investigations, specific patient expertise,
and clinical knowledge are also mandatory. Quite evidently, methodological assumptions as
developed for healthy subjects and implemented in standard software packages may not always
be valid for distorted and pathological brains. There are specific problems for the various clinical
populations and also for defining the functional status of an “individual brain” (as opposed to a
“group brain” in group studies). Whilst fMRI has been used successfully in research for healthy
subjects and patient groups (group brains), the situation is complicated for using fMRI as a
clinical tool for individual patients. Here, patient and disease variability add to the complexity
of fMRI. When imaging patients, every brain is different, not just among patients but also
for the same patient over time (5, 6) as pathological brains can change rapidly (7) and their
function depends on disease stage. In addition, every pathology (even within the same disease) is
different in type, location, extent, and pathophysiological consequences (e.g., concerning effects
on the hemodynamic response function HRF)—this has to be considered for functional imaging
protocols. Due to this complexity, current clinical functional imaging protocols vary considerably
across institutions in non-standardized ways. However, despite this situation, recent reviews
of fMRI for presurgical evaluation of patients with epilepsy or brain tumors recommend the
application of fMRI in certain contexts showing probable or possible usefulness for patients [levels
B and C, (8, 9)]. In this situation and since procedural variability immediately affects validity and
repeatability of fMRI results, a burning question for clinical functional neuroimaging is: can we
standardize clinical fMRI procedures and to what extent?
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At this point it is important to realize that even when focusing
on healthy subject settings, it is difficult to unambiguously
define best practice procedures. Consequently, the recent
COBIDAS report [Best Practices in Data Analysis and
Sharing in Neuroimaging using MRI, (10)] concentrates on
recommendations for data reporting and little on best practice
for experimental design, data acquisition, and preprocessing
issues. Only for statistical modeling more detailed best practice
recommendations are given. Considering the large body of
existing clinical research, we believe that within a clinical
context, some experimental and acquisition recommendations—
which might be helpful over most patient populations and
investigational systems—can also be given. With task-based
fMRI, the most important clinical functional neuroimaging
application to date, the major problems may be categorized
in 2 classes: “Patient related challenges” and “Methodological
challenges.” To approach a standardization of clinical fMRI,
the first step is to identify the most important issues within
every class, which are accessible for defining a procedural
standard. In the following we suggest such starting points
for procedural standardizations, depending on the problem
class.
PATIENT RELATED CHALLENGES
Patient challenges in clinical fMRI particularly concern the
clinical patient state (e.g., paresis, neglect, aphasia) which may
largely differ despite having identical diagnoses. Patient state
may even differ within the same patient from day to day.
Besides patient state, issues with scanning patients concern
performance level (intra-investigational compliance may change
rapidly), ability to support restriction of head movements (in
patients head movement artifacts may be very large), the effect of
brain pathology on theMRI signal (variability of contrast to noise
ratio, limitations for inter-image registration, and analysis) as
well as running medication (e.g., antidepressants, tranquilizers).
All those factors can interfere with and lead to widely different
results and interpretation of functional signals. This may affect
important diagnostic questions like “where are the essential
activations located precisely in the given, distorted pathological
brain?” To approach a standardization for patient related
problems, the authors suggest the following issues for defining a
standard:
(A) Requirements for the patient:
(1) Define a minimum level of vigilance and compliance.
(2) Define a minimum performance level (e.g., for
language task x, minimum required language capabilities
are. . . .).
(B) Requirements for patient handling:
(1) Define a minimum standard for patient preparation
(e.g., adaptation to the system, training of tasks). (2) Define
a minimum performance control (e.g., monitoring of language
or motor output). (3) Define adequate procedures for clinical
head fixation (high restriction efficiency offers the best imaging
option but freeing oneself in case of emergency has to be
considered).
METHODOLOGICAL CHALLENGES
For clinical fMRI standardizations, problems concerning
infrastructure and methodology are also highly important.
Here, profound knowledge and local validation of the hard- and
software used is essential. Many of the methodological problems
are reasons why the techniques have not yet found a broad way
into routine clinical work (11). The following issues might be
accessible for defining a standard:
(A) Requirements for data recording:
(1) What is the minimum equipment necessary (e.g.,
concerning MR systems, medically approved stimulus delivery
systems, patient monitoring, and response systems)? (2) What
are the minimum requirements for clinically feasible and
informative functional neuroimaging protocols? This includes
standards for protocol development, testing, optimization, task
definitions, and design definitions (e.g., use only published
protocols, check advantages of blocked vs. event related designs,
check advantages of resting state vs. task-based fMRI, check
advantages of adding arterial spin labeling (ASL) to gain
additional functional information from a different perspective).
(3)WhichMRI sequence characteristics should be recommended
to allow comparability over many MR systems (e.g., spatial
resolutions, TR values, use of multiband factors, number of
volumes, and minimum scanning time etc.)? This may result
in concrete suggestions of sequence models which might be
immediately copied for resting state fMRI, task based fMRI,
anatomy, DTI etc.
(B) Requirements for data analysis:
(1) What are the acceptable post processing steps and how
should a “clinically significant” brain activation be defined? As
indicated above, model assumptions developed for healthy brains
may not work and a false positive risk has to be balanced against
clinically critical false negatives (12). In general, data analyses
with minimized model assumptions seem most promising.
Recommendations might also include the latest options to
remove residual head motion effects and the simultaneous and
coparative use of various data analysis approaches (e.g., the
classical model-based approaches and those with minimized
assumptions to help differentiation of artifacts from low level
activations). (2) How should the formats for data presentation to
the clinicians be—considering that “final clinical images” always
include an interpretation?
HOW IS THE CURRENT SITUATION OF
STANDARDIZATION EFFORTS?
For experts in clinical fMRI, the topic is not a new one
and has been discussed for decades within dedicated
societies (www.asfnr.org, www.oegfmrt.org, www.
humanbrainmapping.org). However, based on recent critics
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about replicability/reproducibility of neuroimaging data (13–
15), this discussion spread and has meanwhile become a major
topic of larger imaging societies within the fields of brain
mapping, clinical neurosciences, and radiology. New efforts
to standardize functional neuroimaging protocols have been
launched particularly by the Organization for Human Brain
Mapping (OHBM). For MRI based neuroimaging research the
COBIDAS report has been published (10) and a recommendation
on MEG/EEG is in preparation (16). The COBIDAS report
introduces recommendations within seven areas of MRI
neuroimaging: (1) experimental design reporting, (2) image
acquisition reporting, (3) preprocessing reporting, (4) statistical
modeling, (5) results reporting, (6) data sharing, and (7)
reproducibility. From these areas the general recommendations
for procedure reporting may well be applicable for clinical
research and diagnostic patient investigations—although specific
extensions for clinical populations will be required as outlined
above. Similar approaches focused on clinical demands currently
exist on local levels (e.g., Neuroimage WING project Austria,
www.i-med.ac.at/mypoint/thema/678651.html), on specific
topics [European Network for Brain Imaging of Tumors
(ENBIT, www.enbit.ac.uk)] or on specific diseases (e.g., Magnetic
Resonance Imaging in Multiple Sclerosis, www.magnims.eu).
Larger international standardization initiatives are currently
under discussion with an intention to also increase overlap
between radiological societies and functional imaging societies.
These initiatives are mostly focused on neuroimaging with
healthy subjects, however they clearly indicate the need for
extension of these discussions to the field of clinically applied
neuroimaging.
CONCLUSION
In conclusion, we think that current initiatives are helpful
to spread attention on repeatability, reproducibility, and
replicability issues from smaller circles to larger communities
and societies. The goal is to define standards for neuroimaging
wherever possible. We argue for increased awareness and
critical consideration of the specific problems with patients
and clinical environments in the context of clinical fMRI.
Given the broad range of disease related and methodological
variability, defining procedural clinical standards is an utmost
difficult enterprise. Helpful recommendations may need to be
relative (e.g., depending on disease and patient state) and not
absolute. However, for the most important clinical functional
neuroimaging method—task based clinical fMRI—developing
recommendations for the patient- andmethodological challenges
described above seems feasible and is highly desirable tomove the
technology into the clinical realm.
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